Tilia Fiduciary Partners’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-766
Closed -$53K 185
2023
Q2
$53K Sell
766
-436
-36% -$31K 0.05% 201
2023
Q1
$89.3K Sell
1,202
-11
-0.9% -$922 0.09% 151
2022
Q4
$113K Sell
1,213
-50
-4% -$4.83K 0.11% 130
2022
Q3
$112K Hold
1,263
0.11% 126
2022
Q2
$120K Hold
1,263
0.11% 124
2022
Q1
$128K Buy
1,263
+1
+0.1% +$105 0.11% 130
2021
Q4
$130K Buy
+1,262
New +$117K 0.1% 135

Other funds holding CVS

Tilia Fiduciary Partners's CVS Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of CVS Health (CVS) in Q3 2023, closing a stake of 766 shares — an estimated $53K sold.

Tilia Fiduciary Partners first reported a position in CVS in Q4 2021 and held it in 7 quarters. The position peaked at $130K in Q4 2021. 2,114 funds tracked by Wall St. Rank hold CVS as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 766 CVS Health shares in Q3 2023, an estimated $53K.
  • Tilia Fiduciary Partners first reported a position in CVS Health in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's CVS Health position peaked at $130K in Q4 2021.
  • 2,114 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.